CA2311734C
(en)
*
|
2000-04-12 |
2011-03-08 |
Bristol-Myers Squibb Company |
Flash-melt oral dosage formulation
|
US7053092B2
(en)
|
2001-01-29 |
2006-05-30 |
Otsuka Pharmaceutical Co., Ltd. |
5-HT1a receptor subtype agonist
|
AR032641A1
(es)
*
|
2001-01-29 |
2003-11-19 |
Otsuka Pharma Co Ltd |
Agonista de subtipo de receptor 5-ht 1a.
|
MY129350A
(en)
|
2001-04-25 |
2007-03-30 |
Bristol Myers Squibb Co |
Aripiprazole oral solution
|
AR033485A1
(es)
*
|
2001-09-25 |
2003-12-26 |
Otsuka Pharma Co Ltd |
Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
|
US8703772B2
(en)
|
2001-09-25 |
2014-04-22 |
Otsuka Pharmaceutical Co., Ltd. |
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
|
PE20030445A1
(es)
*
|
2001-09-25 |
2003-07-26 |
Otsuka Pharma Co Ltd |
Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
|
TWI324074B
(en)
*
|
2001-10-09 |
2010-05-01 |
Bristol Myers Squibb Co |
Flashmelt oral dosage formulation
|
SE0200301D0
(sv)
*
|
2002-02-01 |
2002-02-01 |
Axon Biochemicals Bv |
Thio-carbostyril derivative
|
ATE428423T1
(de)
*
|
2002-08-20 |
2009-05-15 |
Bristol Myers Squibb Co |
Aripiprazol-komplex-formulierung und verfahren
|
GB0220581D0
(en)
|
2002-09-04 |
2002-10-09 |
Novartis Ag |
Organic Compound
|
AU2003291757A1
(en)
*
|
2002-11-08 |
2004-06-03 |
Bristol-Myers Squibb Company |
Formulations of low solubility bioactive agents and processes for making the same
|
AR042806A1
(es)
*
|
2002-12-27 |
2005-07-06 |
Otsuka Pharma Co Ltd |
Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
|
CN1726039B
(zh)
|
2002-12-27 |
2010-08-18 |
大塚制药株式会社 |
用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂
|
KR100583667B1
(ko)
*
|
2003-01-09 |
2006-05-26 |
오쓰까 세이야꾸 가부시키가이샤 |
아리피프라졸의 제조방법
|
WO2004064752A2
(en)
*
|
2003-01-22 |
2004-08-05 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing sustained release microparticles
|
AU2003230192A1
(en)
*
|
2003-03-21 |
2004-10-11 |
Hetero Drugs Limited |
Novel crystalline forms of aripiprazole
|
US20060270683A1
(en)
*
|
2003-04-25 |
2006-11-30 |
Lohray Braj B |
Polymorphs of aripiprazole
|
CA2428237C
(en)
*
|
2003-05-08 |
2010-07-20 |
Delmar Chemicals Inc. |
Process for the preparation of carbostyril derivatives
|
CN1791430A
(zh)
*
|
2003-05-16 |
2006-06-21 |
辉瑞产品公司 |
非典型抗精神病药物和gaba调节剂、抗惊厥药物或苯并二氮杂䓬类的治疗性组合
|
CN102166359A
(zh)
|
2003-05-23 |
2011-08-31 |
大塚制药株式会社 |
用于治疗情感障碍的喹诺酮衍生物和情绪稳定剂
|
WO2005009990A1
(en)
*
|
2003-07-25 |
2005-02-03 |
Hetero Drugs Limited |
Aripiprazole crystalline forms
|
US20050032811A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Josiah Brown |
Methods for administering aripiprazole
|
US6987111B2
(en)
|
2003-08-06 |
2006-01-17 |
Alkermes Controlled Therapeutics, Ii |
Aripiprazole, olanzapine and haloperidol pamoate salts
|
US20050032781A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Elliot Ehrich |
Methods for administering active agents to CYP 2D6 sensitive patients
|
US20050031713A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Elliot Ehrich |
Methods for administering active agents to CYP3A4 sensitive patients
|
US7160888B2
(en)
*
|
2003-08-22 |
2007-01-09 |
Warner Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
|
ES2331454T1
(es)
*
|
2003-10-16 |
2010-01-05 |
Symed Labs Limited |
Forma cristalina de linezolid.
|
MXPA06004489A
(es)
*
|
2003-10-23 |
2006-06-20 |
Otsuka Pharma Co Ltd |
Formulacion y metodo de aripiprazol inyectable esteril de liberacion controlada.
|
TWI371274B
(en)
|
2003-10-23 |
2012-09-01 |
Bristol Myers Squibb Co |
Process for making sterile aripiprazole of desired mean particle size
|
GB0326148D0
(en)
|
2003-11-10 |
2003-12-17 |
Lilly Co Eli |
Morpholine derivatives
|
US7714129B2
(en)
*
|
2003-12-16 |
2010-05-11 |
Teva Pharmaceutical Industries Ltd. |
Methods of preparing anhydrous aripiprazole form II
|
US7504504B2
(en)
*
|
2003-12-16 |
2009-03-17 |
Teva Pharmaceutical Industries Ltd. |
Methods of preparing aripiprazole crystalline forms
|
CN1304373C
(zh)
*
|
2003-12-25 |
2007-03-14 |
成都康弘科技实业(集团)有限公司 |
阿立哌唑的制备方法和中间体
|
US7361756B2
(en)
*
|
2004-02-05 |
2008-04-22 |
Teva Pharmaceutical Industries Ltd. |
Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril
|
CA2555289A1
(en)
*
|
2004-02-05 |
2005-08-25 |
Ben-Zion Dolitzky |
Process for preparing aripiprazole
|
CN100497325C
(zh)
*
|
2004-04-21 |
2009-06-10 |
齐鲁制药有限公司 |
哌嗪衍生物及其在制备喹啉酮衍生物中的用途
|
US7507823B2
(en)
*
|
2004-05-06 |
2009-03-24 |
Bristol-Myers Squibb Company |
Process of making aripiprazole particles
|
CA2565996A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Pfizer Products Inc. |
Combination of atypical antipsychotics and 5-ht1b receptor antagonists
|
PE20060437A1
(es)
|
2004-06-18 |
2006-06-08 |
Novartis Ag |
COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
|
WO2006012237A2
(en)
*
|
2004-06-25 |
2006-02-02 |
Shanghai Institute Of Pharmaceutical Industry |
Aripiprazole crystaline forms and associated methods
|
TW200616608A
(en)
*
|
2004-07-09 |
2006-06-01 |
Forest Laboratories |
Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
|
GB0415746D0
(en)
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
EP1797039A1
(en)
*
|
2004-09-13 |
2007-06-20 |
Matrix Laboratories Ltd |
Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts
|
CN101068789B
(zh)
*
|
2004-10-08 |
2010-12-15 |
苏文生命科学有限公司 |
用于制备阿立哌唑的新中间体及其制备方法、阿立哌唑的制备方法
|
DE102005048694A1
(de)
*
|
2004-10-12 |
2006-05-18 |
Chemagis Ltd. |
Verbesserte Verfahren zur Herstellung von 7-Hydroxy-3,4-dihydro-2(1H)-quinolinon und dessen Verwendung in der Herstellung von Aripiprazol
|
DE102005048695A1
(de)
*
|
2004-10-12 |
2006-05-18 |
Chemagis Ltd. |
Verfahren zur Herstellung und Reinigung von Carbostyrilverbindungen wie beispielsweise Aripiprazol und 7-(4-Halobutoxy)-3,4-dihydro-2(1H)-quinolinonen
|
GB0424564D0
(en)
|
2004-11-05 |
2004-12-08 |
Novartis Ag |
Organic compounds
|
EP1812396A1
(en)
*
|
2004-11-18 |
2007-08-01 |
Synthon B.V. |
Crystalline aripiprazole solvates
|
WO2006053781A1
(en)
*
|
2004-11-18 |
2006-05-26 |
Synthon B.V. |
Process of making crystalline aripiprazole
|
CN1303068C
(zh)
*
|
2005-01-11 |
2007-03-07 |
中国人民解放军第二军医大学 |
一种阿立哌唑的制备方法
|
CN101107242B
(zh)
*
|
2005-01-27 |
2011-08-10 |
桑多斯股份公司 |
阿立哌唑的盐
|
EP1686117A1
(en)
*
|
2005-01-27 |
2006-08-02 |
Sandoz AG |
Polymorph and solvates of aripiprazole
|
EP1686126A1
(en)
*
|
2005-01-27 |
2006-08-02 |
Sandoz AG |
Salts of aripiprazole
|
CZ300456B6
(cs)
*
|
2005-02-15 |
2009-05-27 |
Zentiva, A. S. |
Zpusob prípravy vinanu aripiprazolu v krystalické forme
|
CZ300352B6
(cs)
*
|
2005-02-15 |
2009-04-29 |
Zentiva, A. S. |
Zpusob prípravy fosforecnanu aripiprazolu
|
WO2006090272A1
(en)
*
|
2005-02-22 |
2006-08-31 |
Warner-Lambert Company Llc |
Isoquinoline [1,8]naphthyridin-2-ones and related compounds for treatment of schizophrenia
|
WO2006097343A1
(en)
†
|
2005-03-17 |
2006-09-21 |
Synthon B.V. |
Process of making crystalline type ii aripiprazole
|
ES2526415T3
(es)
*
|
2005-03-17 |
2015-01-12 |
Synthon B.V. |
Comprimidos farmacéuticos de aripiprazol cristalino de tipo II
|
CA2603049A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Warner-Lambert Company Llc |
Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
|
GB0507298D0
(en)
|
2005-04-11 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
TWI320783B
(en)
|
2005-04-14 |
2010-02-21 |
Otsuka Pharma Co Ltd |
Heterocyclic compound
|
CZ300351B6
(cs)
*
|
2005-05-26 |
2009-04-29 |
Zentiva, A. S. |
Zpusob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu
|
CN100432053C
(zh)
*
|
2005-06-07 |
2008-11-12 |
上海医药工业研究院 |
阿立哌唑晶型及其制备方法
|
HUP0500683A3
(en)
*
|
2005-07-14 |
2009-03-30 |
Egis Gyogyszergyar Nyilvanosan |
New arylpiprazole salts for producing pharmaceutical composition
|
TWI329641B
(en)
|
2005-08-31 |
2010-09-01 |
Otsuka Pharma Co Ltd |
(benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
|
US20070148100A1
(en)
*
|
2005-09-15 |
2007-06-28 |
Elan Pharma International, Limited |
Nanoparticulate aripiprazole formulations
|
KR20070088750A
(ko)
|
2005-09-29 |
2007-08-29 |
테바 파마슈티컬 인더스트리즈 리미티드 |
무수 아리피프라졸 제ii형의 제조 방법
|
CZ299485B6
(cs)
*
|
2005-10-11 |
2008-08-13 |
Zentiva, A. S. |
Zpusob výroby aripiprazolu
|
GB0525672D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
GB0525673D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
JP2008537540A
(ja)
*
|
2005-12-22 |
2008-09-18 |
テバ ファーマシューティカル インダストリーズ リミティド |
アリピプラゾールの粒径を小さくする方法
|
US20070149782A1
(en)
*
|
2005-12-23 |
2007-06-28 |
Michael Brand |
Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole
|
US20090054455A1
(en)
*
|
2006-02-03 |
2009-02-26 |
Dr. Reddy's Laboratories Ltd. |
Aripiprazole co-crystals
|
WO2007099828A1
(ja)
|
2006-02-23 |
2007-09-07 |
Shionogi & Co., Ltd. |
環式基で置換された含窒素複素環誘導体
|
US20070213535A1
(en)
*
|
2006-03-07 |
2007-09-13 |
Chemagis Ltd. |
Process for the manufacture of aripiprazole by using purified carbostyril compounds such as 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones
|
US20060223820A1
(en)
*
|
2006-03-21 |
2006-10-05 |
Chemagis Ltd. |
Crystalline aripiprazole salts and processes for preparation and purification thereof
|
WO2007113846A1
(en)
*
|
2006-04-03 |
2007-10-11 |
Alembic Limited |
A process for the preparation of aripiprazole
|
EP1845088B1
(en)
*
|
2006-04-10 |
2009-07-22 |
Ranbaxy Laboratories Limited |
An improved process for the preparation of aripipirazole
|
EP2041304B1
(en)
|
2006-06-12 |
2011-09-07 |
Hadasit Medical Research Services & Development Limited |
Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication
|
WO2007148191A2
(en)
*
|
2006-06-20 |
2007-12-27 |
Orchid Chemicals & Pharmaceuticals Limited |
An improved process for the preparation of aripiprazole
|
WO2008001188A2
(en)
*
|
2006-06-29 |
2008-01-03 |
Cadila Pharmaceuticals Limited |
An improved process for the preparation of substantially pure aripiprazole
|
US7799790B2
(en)
*
|
2006-07-20 |
2010-09-21 |
Helm Ag |
Amorphous aripiprazole and process for the preparation thereof
|
EP1880714A1
(en)
*
|
2006-07-20 |
2008-01-23 |
Helm AG |
Amorphous Aripiprazole and Process for the Preparation thereof
|
TR200604349A2
(tr)
|
2006-08-15 |
2008-03-21 |
NOBEL İLAÇ SANAYii VE TiCARET A.Ş. |
Aripiprazol içeren farmasötik bileşimler
|
EP2063893A2
(en)
*
|
2006-08-24 |
2009-06-03 |
Concert Pharmaceuticals Inc. |
3,4-dihydro-2 (1h) - quinolinone and 2 (1h)-quinolinone derivatives
|
SI2081904T1
(sl)
*
|
2006-09-22 |
2011-05-31 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Aripiprazol hemifumarat in postopek za njegovo pripravo
|
EP2084133A2
(en)
*
|
2006-09-28 |
2009-08-05 |
Cadila Healthcare Limited |
Process for preparing crystalline aripiprazole
|
EP2079723B1
(en)
*
|
2006-10-24 |
2012-12-19 |
Cambrex Charles City, Inc. |
Process for preparing anhydrous aripiprazole type i
|
AU2007344864A1
(en)
*
|
2007-01-26 |
2008-07-31 |
Otsuka Pharmaceutical Co., Ltd. |
Marker for detecting the proposed efficacy of treatment
|
EP1972628A1
(en)
*
|
2007-03-21 |
2008-09-24 |
Schwarz Pharma Ag |
Indolizines and aza-analog derivatives thereof as CNS active compounds
|
TW200848041A
(en)
|
2007-03-30 |
2008-12-16 |
Otsuka Pharma Co Ltd |
A medicament for treating schizophrenia comprising cilostazol
|
NZ582124A
(en)
*
|
2007-05-21 |
2012-07-27 |
Reviva Pharmaceuticals Inc |
Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
|
US20100130744A1
(en)
*
|
2007-06-01 |
2010-05-27 |
Mahesh Nagarimadugu |
Process for the preparation of aripiprazole
|
US20080299216A1
(en)
*
|
2007-06-01 |
2008-12-04 |
Protia, Llc |
Deuterium-enriched aripiprazole
|
NZ582415A
(en)
*
|
2007-07-31 |
2012-05-25 |
Otsuka Pharma Co Ltd |
Methods for producing aripiprazole suspension and freeze-dried formulation
|
GB2456183A
(en)
*
|
2008-01-04 |
2009-07-08 |
Gw Pharma Ltd |
Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
|
PT2082735E
(pt)
|
2008-01-23 |
2010-10-12 |
Helm Ag |
Aripripazole amorfo e processo para a sua preparação
|
CN101538252B
(zh)
*
|
2008-03-20 |
2011-04-20 |
成都康弘药业集团股份有限公司 |
阿立哌唑的制备方法及其中间体
|
US7964605B2
(en)
*
|
2008-05-29 |
2011-06-21 |
Sk Holdings Co., Ltd. |
Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
|
US7985752B2
(en)
*
|
2008-05-29 |
2011-07-26 |
Sk Holdings Co., Ltd. |
Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
|
WO2010079506A2
(en)
|
2008-06-23 |
2010-07-15 |
Torrent Pharmaceuticals Ltd. |
Pharmaceutical composition of aripiprazole
|
EP2321011A1
(en)
*
|
2008-06-25 |
2011-05-18 |
Pfizer Inc. |
Diaryl compounds and uses thereof
|
EP2233471A1
(en)
|
2009-02-06 |
2010-09-29 |
Adamed Sp. z o.o. |
A salt of 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-quinolinone with 5-sulfosalicylic acid and its preparation process
|
WO2010106551A2
(en)
*
|
2009-03-09 |
2010-09-23 |
Neuland Laboratories Ltd. |
A process for the manufacture of pure anhydrous aripiprazole form b
|
EP2238976B1
(en)
|
2009-04-03 |
2012-06-27 |
Hexal AG |
Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
|
JP5664871B2
(ja)
|
2009-06-19 |
2015-02-04 |
株式会社 メドレックス |
アリピプラゾールと有機酸を有効成分とする外用剤組成物
|
HRP20171415T4
(hr)
|
2009-06-25 |
2023-03-03 |
Alkermes Pharma Ireland Limited |
Heterociklični spojevi za liječenje neuroloških i psiholoških poremećaja
|
JP5732453B2
(ja)
|
2009-06-25 |
2015-06-10 |
アルカーメス ファーマ アイルランド リミテッド |
Nh酸性化合物のプロドラッグ
|
WO2011023796A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Healthcare Products B.V. |
Bifeprunox for treating addiction
|
AU2010293647B2
(en)
|
2009-09-11 |
2015-06-25 |
Otsuka Pharmaceutical Co., Ltd. |
Therapeutic agent for chronic pain
|
WO2011030213A1
(en)
|
2009-09-14 |
2011-03-17 |
Jubilant Organosys Limited |
Improved process for the preparation of 7.(4-bromobutoxy) 3,4-dihydrocarbostyril, a precursor of aripiprazole
|
EA201200485A1
(ru)
|
2009-09-15 |
2012-10-30 |
Рациофарм Гмбх |
Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
|
TR201000948A1
(tr)
|
2010-02-09 |
2011-08-22 |
Sanovel İlaç San.Ve Ti̇c.A.Ş. |
Aripiprazol formülasyonları.
|
WO2011159871A2
(en)
|
2010-06-16 |
2011-12-22 |
Embera Neurotherapeutics, Inc |
Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
|
WO2011163594A2
(en)
|
2010-06-24 |
2011-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
WO2012003418A2
(en)
|
2010-07-02 |
2012-01-05 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine d2 receptors
|
RS65091B1
(sr)
|
2010-08-23 |
2024-02-29 |
Alkermes Pharma Ireland Ltd |
Postupci za lečenje povećanja telesne težine indukovanog antipsihoticima
|
JP5575269B2
(ja)
|
2010-08-24 |
2014-08-20 |
大塚製薬株式会社 |
カルボスチリル誘導体並びにシリコーンオイル及び/又はシリコーンオイル誘導体を含有する懸濁液及びケーキ組成物
|
JP5916746B2
(ja)
|
2010-11-15 |
2016-05-11 |
エージンバイオ, インコーポレイテッド |
認知障害を処置するためのピリダジン誘導体、組成物、および方法
|
AR083884A1
(es)
|
2010-11-16 |
2013-03-27 |
Otsuka Pharma Co Ltd |
Jeringa prellenable de doble camara y relleno de aripiprazol en la jeringa
|
MY163272A
(en)
|
2011-01-24 |
2017-08-30 |
Otsuka Pharma Co Ltd |
Medical device containing a cake composition comprising aripiprazole as an active ingredient,and a cake composition comprising aripiprazole as an active ingredient
|
PL3156056T3
(pl)
|
2011-03-18 |
2024-04-29 |
Alkermes Pharma Ireland Limited |
Kompozycje farmaceutyczne zawierające estry sorbitanu
|
WO2012131451A1
(en)
|
2011-03-30 |
2012-10-04 |
Jubilant Life Sciences Limited |
Process for producing aripiprazole in anhydrous type i crystals
|
KR101340214B1
(ko)
|
2011-03-31 |
2013-12-10 |
주식회사 대웅제약 |
무수 아리피프라졸 ⅱ형 결정의 제조방법
|
JO3410B1
(ar)
|
2011-06-07 |
2019-10-20 |
Otsuka Pharma Co Ltd |
تركيبة أريبيبرازول مجفف بالتبريد
|
TW201309651A
(zh)
|
2011-06-29 |
2013-03-01 |
Otsuka Pharma Co Ltd |
阿立哌唑(aripiprazole)無水物B形結晶微粒子之製造方法
|
GR1007722B
(el)
|
2011-08-05 |
2012-10-18 |
Φαρματεν Αβεε, |
Μεθοδος για την παρασκευη της αριπιπραζολης
|
ES2715562T3
(es)
|
2011-12-15 |
2019-06-04 |
Alkermes Pharma Ireland Ltd |
Profármacos de compuestos de amina secundaria
|
CN103172563B
(zh)
*
|
2011-12-26 |
2015-03-25 |
北京京卫燕康药物研究所有限公司 |
小粒径的晶型i阿立哌唑的工业化制备
|
WO2013100878A1
(en)
|
2011-12-27 |
2013-07-04 |
Mahmut Bilgic |
Pharmaceutical formulations comprising aripiprazole
|
WO2014104989A1
(en)
|
2011-12-27 |
2014-07-03 |
Mahmut Bilgic |
Pharmaceutical compositions comprising aripiprazole
|
TW201343201A
(zh)
|
2012-03-06 |
2013-11-01 |
Otsuka Pharma Co Ltd |
持續釋放型口服固體製劑
|
NZ630703A
(en)
|
2012-03-19 |
2017-02-24 |
Alkermes Pharma Ireland Ltd |
Pharmaceutical compositions comprising glycerol esters
|
CA2867121C
(en)
|
2012-03-19 |
2021-05-25 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising fatty acid esters
|
JP6333802B2
(ja)
|
2012-03-19 |
2018-05-30 |
アルカームス ファーマ アイルランド リミテッド |
ベンジルアルコールを含む医薬組成物
|
JOP20200109A1
(ar)
|
2012-04-23 |
2017-06-16 |
Otsuka Pharma Co Ltd |
مستحضر قابل للحقن
|
KR101571670B1
(ko)
|
2012-08-08 |
2015-11-25 |
주식회사 씨엠지제약 |
아리피프라졸을 포함하는 경구용 속용 필름 제제
|
EP2897592B1
(en)
|
2012-09-19 |
2020-02-19 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions having improved storage stability
|
WO2014059363A1
(en)
*
|
2012-10-11 |
2014-04-17 |
Antrim Pharmaceuticals Llc |
Oral solution formulations of aripiprazole
|
PL2908859T3
(pl)
|
2012-10-16 |
2017-10-31 |
Arven Ilac Sanayi Ve Ticaret As |
Formulacje arypiprazolu
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
AR096131A1
(es)
|
2013-04-30 |
2015-12-09 |
Otsuka Pharma Co Ltd |
Preparado oral sólido que comprende aripiprazol y un método para producir un preparado oral sólido que comprende aripiprazol
|
US10525057B2
(en)
|
2013-09-24 |
2020-01-07 |
Otsuka Pharmaceutical Co., Ltd. |
Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
|
EP3065700A1
(en)
|
2013-11-07 |
2016-09-14 |
Synthon B.V. |
Orodispersible pharmaceutical compositions comprising aripiprazole
|
CA2934553C
(en)
|
2013-12-20 |
2023-10-31 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US9452131B2
(en)
|
2014-03-20 |
2016-09-27 |
Alkermes Pharma Ireland Limited |
Aripiprazole formulations having increased injection speeds
|
KR20160139704A
(ko)
|
2015-05-28 |
2016-12-07 |
주식회사 씨엠지제약 |
아리피프라졸을 포함하는 경구용 속용 필름 제제, 및 이의 제조방법
|
CN107920989A
(zh)
|
2015-06-08 |
2018-04-17 |
考里安国际公司 |
用于透皮递送阿立哌唑的制剂
|
IL256354B
(en)
|
2015-06-19 |
2022-09-01 |
Agenebio Inc |
History of benzodiazepines, preparations and their use for the treatment of cognitive impairment
|
US20180185375A1
(en)
*
|
2015-06-22 |
2018-07-05 |
Embera Neurotherapeutics, Inc. |
Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders
|
CN106608875A
(zh)
|
2015-10-26 |
2017-05-03 |
江苏恩华药业股份有限公司 |
一种稠和杂环类衍生物合成及其应用
|
WO2018020325A1
(en)
|
2016-07-28 |
2018-02-01 |
Mylan Laboratories Ltd, |
Process for preparing sterile aripiprazole formulation
|
CN108069900B
(zh)
*
|
2016-11-08 |
2022-09-23 |
齐鲁制药有限公司 |
阿立哌唑盐酸盐的制备方法和用途
|
TR201617675A2
(tr)
|
2016-12-02 |
2018-06-21 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Ari̇pi̇prazole monohi̇drat formülasyonlarinin ağizda dağilan tablet formu
|
US11505555B2
(en)
|
2016-12-19 |
2022-11-22 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
AU2018230521B2
(en)
|
2017-03-10 |
2022-02-03 |
Embera Neurotherapeutics, Inc. |
Pharmaceutical compositions and uses thereof
|
US20200140410A1
(en)
|
2017-07-28 |
2020-05-07 |
Interquim, S.A. |
Process for the preparation of aripiprazole lauroxil
|
CN109498556A
(zh)
*
|
2017-09-15 |
2019-03-22 |
万特制药(海南)有限公司 |
阿立哌唑口服溶液及其制备方法
|
US11273158B2
(en)
|
2018-03-05 |
2022-03-15 |
Alkermes Pharma Ireland Limited |
Aripiprazole dosing strategy
|
BR112020026062B1
(pt)
|
2018-06-19 |
2023-04-04 |
Agenebio, Inc |
Compostos derivados de benzodiazepina ou um sal farmaceuticamente aceitavel, isômero ou combinação dos mesmos, composição farmacêutica compreendendo os mesmos e usos dos mesmos para o tratamento de comprometimento cognitivo, câncer cerebral e psicose da doença de parkinson
|
CN109180577B
(zh)
*
|
2018-10-15 |
2021-11-16 |
迪嘉药业集团有限公司 |
一种阿立哌唑的制备方法
|
KR102128883B1
(ko)
|
2019-10-02 |
2020-07-01 |
(주)삼화바이오팜 |
고순도 아리피프라졸의 신규 결정형 및 이의 제조방법
|
US20240217977A1
(en)
*
|
2021-03-31 |
2024-07-04 |
Blueprint Medicines Corporation |
Diazepanone-fused pyrimidine compounds, compositions and medicinal applications thereof
|
TWI820847B
(zh)
*
|
2021-08-05 |
2023-11-01 |
大陸商上海樞境生物科技有限公司 |
含三并環類衍生物調節劑、其製備方法和應用
|
CN114751873A
(zh)
*
|
2022-04-25 |
2022-07-15 |
扬州市普林斯医药科技有限公司 |
一种1-(2,3-二氯苯基)哌嗪的制备方法
|
WO2024039886A1
(en)
|
2022-08-19 |
2024-02-22 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|